Case number 1:17-cv-01699
Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 8, 2019 | 24 | Order (3) Docket Text: CONSENT JUDGMENT re Aurobindo, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 5/7/19. (ntl) |
| May 3, 2019 | 23 | Proposed Consent Judgment (3) Docket Text: PROPOSED CONSENT JUDGMENT (Between Onyx Therapeutics, Inc. and Aurobindo Pharma USA, Inc.) by Onyx Therapeutics, Inc.. (Dellinger, Megan) |
| Feb 28, 2019 | 22 | Notice of Change of Address (1) Docket Text: NOTICE of Change of Address by Arthur G. Connolly, III (Connolly, Arthur) |
| Jan 23, 2019 | 21 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Aurobindo Pharma USA, Inc.'s Supplemental Objections and Responses to Plaintiff's Joint Interrogatory No. 5 filed by Aurobindo Pharma USA, Inc..(Connolly, Arthur) |
| Jan 22, 2019 | 20 | Redacted Document (30) Docket Text: REDACTED VERSION of [19] Answer to Counterclaim by Onyx Therapeutics, Inc.. (Dellinger, Megan) |
| Jan 8, 2019 | 18 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Counsel by Aurobindo Pharma USA, Inc. for Mary I. Akhimien, Esquire (Akhimien, Mary) |
| Dec 28, 2018 | 17 | Redacted Document (30) Docket Text: REDACTED VERSION of [16] Amended Answer to Complaint, Counterclaim by Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Mar 20, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] STIPULATION and Covenant Not to Sue Regarding U.S. Patent Nos. 7,232,818; 7,491,704; 8,129,346; and 8,207,297 filed by Onyx Therapeutics, Inc. Signed by Judge Leonard P. Stark on 3/20/18. (ntl) |
| Mar 16, 2018 | 15 | Stipulation (3) Docket Text: STIPULATION and Covenant Not to Sue Regarding U.S. Patent Nos. 7,232,818; 7,491,704; 8,129,346; and 8,207,297 by Onyx Therapeutics, Inc.. (Noreika, Maryellen) |
| Feb 7, 2018 | N/A | SO ORDERED (0) |
| Feb 7, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:16-cv-00988-LPS. (ntl) |
| Feb 5, 2018 | 14 | Notice Requesting Removal of Co-Counsel (8) Docket Text: NOTICE requesting Clerk to remove Filko Prugo as co-counsel. Reason for request: no longer associated with O'Melveny & Myers LLP. (Noreika, Maryellen) |
| Feb 2, 2018 | 13 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosures Identifying Defendant Aurobindo Pharma USA, Inc.'s Accused Products and Plaintiff's Asserted Patents filed by Onyx Therapeutics, Inc..(Noreika, Maryellen) |
| Feb 1, 2018 | 11 | Answer to Counterclaim (14) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Onyx Therapeutics, Inc..(Blumenfeld, Jack) |
| Feb 1, 2018 | 12 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Consolidate by Onyx Therapeutics, Inc.. (Noreika, Maryellen) |
| Jan 22, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Steven J. Moore for Aurobindo Pharma USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Jan 19, 2018 | N/A | SO ORDERED (0) |
| Jan 18, 2018 | 8 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against Onyx Therapeutics, Inc. by Aurobindo Pharma USA, Inc..(Akhimien, Mary) |
| Jan 18, 2018 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aurobindo Pharma USA, Inc.. (Akhimien, Mary) |
| Jan 18, 2018 | 10 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore of Withers Bergman LLP - filed by Aurobindo Pharma USA, Inc.. (Akhimien, Mary) |
| Dec 20, 2017 | N/A | SO ORDERED (0) |
| Dec 18, 2017 | 7 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to January 18, 2018 - filed by Aurobindo Pharma USA, Inc.. (Connolly, Arthur) |
| Nov 29, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Nov 29, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Onyx Therapeutics, Inc.. Aurobindo Pharma USA, Inc. served on 11/28/2017, answer due 12/19/2017. (Blumenfeld, Jack) |
| Nov 22, 2017 | 1 | Complaint (26) |
| Nov 22, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma USA, Inc. on 11/22/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lmm) |
| Nov 22, 2017 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Onyx Pharmaceuticals, Inc. for Onyx Therapeutics, Inc. filed by Onyx Therapeutics, Inc.. (lmm) |
| Nov 22, 2017 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,173,857 B2; 7,232,818 B2; 7,491,704 B2; 7,491,704 B2; 8,129,346 B2. (lmm) |
| Nov 22, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/12/2017. Date of Expiration of Patent: SEE ATTACHED .Thirty Month Stay Deadline: 4/12/2020. (lmm) |
| Nov 22, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lmm) |
| Nov 22, 2017 | 1 | Civil Cover Sheet (2) |
| Nov 22, 2017 | 1 | Exhibit A - I (343) |
| Nov 22, 2017 | 1 | Main Document (26) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2271035.) - filed by Onyx Therapeutics, Inc.. (Attachments: # (1) Exhibit A - I, # (2) Civil Cover Sheet)(lmm) |
| Nov 22, 2017 | 1 | Complaint* (1) |
